ArticleFrontiers in oncology2025

Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET

Wenjing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.